JNGLX
Price
$66.74
Change
-$0.42 (-0.63%)
Updated
Jun 13 closing price
Net Assets
4.35B
LHCVX
Price
$18.50
Change
-$0.10 (-0.54%)
Updated
Jun 13 closing price
Net Assets
7.33M
Interact to see
Advertisement

JNGLX vs LHCVX

Header iconJNGLX vs LHCVX Comparison
Open Charts JNGLX vs LHCVXBanner chart's image
Janus Henderson Global Life Sciences D
Price$66.74
Change-$0.42 (-0.63%)
VolumeN/A
Net Assets4.35B
Lord Abbett Health Care R6
Price$18.50
Change-$0.10 (-0.54%)
VolumeN/A
Net Assets7.33M
JNGLX vs LHCVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCVX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.35B vs. LHCVX (7.33M). LHCVX pays higher dividends than JNGLX: LHCVX (0.61) vs JNGLX (0.36). JNGLX was incepted earlier than LHCVX: JNGLX (26 years) vs LHCVX (6 years). LHCVX (2.99) is less costly to investors than JNGLX (0.80). LHCVX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCVX has a lower initial minimum investment than JNGLX: LHCVX (0) vs JNGLX (2500). LHCVX annual gain was more profitable for investors over the last year : -5.64 vs. JNGLX (-11.98). JNGLX return over 5 years is better than : 13.58 vs. LHCVX (10.90).
JNGLXLHCVXJNGLX / LHCVX
Total Expense Ratio0.800.68118%
Annual Report Gross Expense Ratio0.802.9927%
Fund Existence26 years6 years-
Gain YTD-1.694-4.78635%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B7.33M59,337%
Annual Yield % from dividends0.360.6160%
Returns for 1 year-11.98-5.64212%
Returns for 3 years20.7121.2497%
Returns for 5 years13.5810.90124%
Returns for 10 years12.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUSRX10.51N/A
N/A
Lazard US Systematic Small Cap Eq R6
FEKFX16.57-0.17
-1.02%
Fidelity Equity-Income K6
MMIEX15.06-0.17
-1.12%
MM S&P 500® Index Svc
PGODX75.66-1.03
-1.34%
Putnam Large Cap Growth R5
CCTRX11.83-0.77
-6.11%
Columbia Small Cap Value II R